N/A
Average AnalystN/A
Top AnalystVery Bearish
Stock Target AdvisorN/A
Average UserCAD 0.21
0.00 (0.00)%
CAD 0.02B
0.04M
CAD -1.00
BNXT:CA
Based on the BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11) stock forecast from 0 analysts, the average analyst target price for BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11) is not available over the next 12 months. BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11) is Very Bearish, which is based on 0 positive signals and 2 negative signals. At the last closing, BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11)’s stock price was CAD 0.21. BioNxt Solutions Inc. (formerly was XPHY/XPhyto Therapeutics Corp. until 2022-11-11)’s stock price has changed by +5.00% over the past week, -25.00% over the past month and 0% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock is trading high compared to its peers median on a price to book value basis.
The company had negative total free cash flow in the most recent four quarters.